GWSG
XERS icon

GPS Wealth Strategies Group’s Xeris Biopharma Holdings XERS Stock Holding History

GPS Wealth Strategies Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-65,089
Closed -$530K – 1603
2025
Q3 		$530K Buy
65,089
+164
+0.3% +$1.09K 0.06% 182
2025
Q2 		$303K Sell
64,925
-2,000
-3% -$9.16K 0.03% 252
2025
Q1 		$367K Hold
66,925
– – 0.05% 215
2024
Q4 		$227K Buy
66,925
+3,900
+6% +$12.5K 0.03% 274
2024
Q3 		$180K Buy
63,025
+1,000
+2% +$2.57K 0.02% 324
2024
Q2 		$140K Hold
62,025
– – 0.02% 332
2024
Q1 		$137K Hold
62,025
– – 0.02% 317
2023
Q4 		$146K Sell
62,025
-2,000
-3% -$3.69K 0.03% 288
2023
Q3 		$119K Hold
64,025
– – 0.02% 326
2023
Q2 		$168K Hold
64,025
– – 0.03% 261
2023
Q1 		$104K Hold
64,025
– – 0.02% 342
2022
Q4 		$85.2K Sell
64,025
-1,000
-2% -$1.41K 0.03% 109
2022
Q3 		$101K Hold
65,025
– – 0.03% 304
2022
Q2 		$100K Buy
+65,025
New +$137K 0.03% 318
2022
Q1 		– Sell
-59,025
Closed -$173K – 1165
2021
Q4 		$173K Buy
59,025
+1,000
+2% +$2.16K 0.04% 228
2021
Q3 		$142K Buy
58,025
+9,000
+18% +$26.1K 0.04% 236
2021
Q2 		$200K Buy
49,025
+2,000
+4% +$7.63K 0.05% 203
2021
Q1 		$212K Buy
47,025
+1,000
+2% +$5.39K 0.06% 182
2020
Q4 		$226K Buy
46,025
+525
+1% +$2.63K 0.08% 156
2020
Q3 		$270K Buy
+45,500
New +$182K 0.11% 123

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GPS Wealth Strategies Group's XERS Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Xeris Biopharma Holdings (XERS) in Q4 2025, closing a stake of 65,089 shares — an estimated $530K sold.

GPS Wealth Strategies Group first reported a position in XERS in Q3 2020 and held it in 20 quarters. The position peaked at $530K in Q3 2025. 225 funds tracked by Wall St. Rank hold XERS as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Xeris Biopharma Holdings position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 65,089 Xeris Biopharma Holdings shares in Q4 2025, an estimated $530K.
  • GPS Wealth Strategies Group first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 20 quarters.
  • GPS Wealth Strategies Group's Xeris Biopharma Holdings position peaked at $530K in Q3 2025.
  • 225 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.